Skip to Content

Join the 'Betaseron' group to help and get support from people like you.

Betaseron News

Treating Early Symptoms of MS May Extend Time to Diagnosis

Posted 11 Aug 2016 by Drugs.com

THURSDAY, Aug. 11, 2016 – Starting multiple sclerosis (MS) treatment when the first signs of the disabling disease appear may delay the period before the condition is definitively diagnosed or a relapse occurs, new long-term research indicates. Researchers found that people who received early treatment for symptoms consistent with the onset of MS were one-third less likely to eventually be ...

FDA Approves Betaconnect Electronic Autoinjector for the Treatment of Relapsing-Remitting Multiple Sclerosis

Posted 28 Sep 2015 by Drugs.com

WHIPPANY, N.J., Sept. 25, 2015 /PRNewswire/ – Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) approved Betaconnect, the first and only electronic autoinjector in the treatment of relapsing-remitting multiple sclerosis (RRMS). Betaconnect will be available exclusively to Betaseron (interferon beta-1b) patients beginning in early 2016. Betaseron is a prescription ...

Neurology Group Lists Procedures That May Be Unneeded

Posted 8 Mar 2013 by Drugs.com

FRIDAY, March 8 – Five tests, procedures and treatments that neurologists and their patients should question are outlined in a list released by the American Academy of Neurology (AAN) as part of the Choosing Wisely campaign. "With one in six people affected by a brain disease, such as headache, multiple sclerosis and stroke, our goal is to have patients discuss our Choosing Wisely ...

Drug Widely Used to Treat MS May Not Slow Progression

Posted 17 Jul 2012 by Drugs.com

TUESDAY, July 17 – Interferon beta, a widely used treatment for multiple sclerosis, does not stave off the time to disability, new research finds. However, prior studies have found that interferon beta does reduce MS flare ups, so patients should continue taking it, researchers said. The new study is published in the July 18 issue of the Journal of the American Medical Association. In multiple ...

FDA Medwatch Alert: Betaseron (interferon beta-1b)

Posted 22 Apr 2005 by Drugs.com

Berlex, Inc. reminded healthcare professionals of the prescribing information for Betaseron (interferon beta-1b) as it pertains to hepatic toxicity. Betaseron is approved for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. There have been reports during post-marketing safety surveillance of serious hepatic injury including autoimmune ...

Ask a Question

Further Information

Related Condition Support Groups

Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Colorectal Cancer

Betaseron Patient Information at Drugs.com